You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 126 No. 1, July 1970 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (14)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Applied and Induced Interferon in the Prophylaxis and Treatment of Leukemia

E. Frederick Wheelock, MD, PhD

Arch Intern Med. 1970;126(1):64-68.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The discovery that many forms of murine leukemia are of virus etiology has provided scientific investigators with an animal model system in which the mechanisms of neoplastic transformation can be studied experimentally. Studies of this model have been stimulated by an increasing belief that viruses may either cause or be a necessary component in a multistage induction of human leukemia. For this reason, many investigators in recent years have directed their efforts towards developing effective ways of either preventing murine virus leukemia or curing the disease once it has become established. The approaches employed in these efforts have, in the main, consisted of stimulating natural host defense mechanisms against infectious agents.

The use of formalinized virus as an immunoprophylactic agent has proved to be as effective in murine leukemia as in many nononcogenic viral infections of man. However, development of a vaccine against human leukemia must await the isolation and . . . [Full Text PDF of this Article]


Author Affiliations

Cleveland

From Case Western Reserve University, Cleveland. Dr. Wheelock is now on leave of absence at the Clinical Research Centre Laboratories, National Institute for Medical Research, London.


Footnotes

Received for publication Oct 20, 1969; accepted Jan 26, 1970.

Reprint requests to Department of Community Health, Wearn Research Building, University Hospitals, Cleveland 44106 (Dr. Wheelock).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1970 American Medical Association. All Rights Reserved.